Follow Us :

Ministry of Commerce & Industry, Department of Commerce, Directorate General of Foreign Trade, has issued a significant amendment through Notification No. 72/2023, dated 11th March, 2024. This amendment specifically targets the export policy of Human Biological Samples under Chapter 30 of the ITC HS Schedule-2.

Export Policy of Human Biological Samples under Chapter 30 of [ITC HS schedule-2 of export policy is amended to the extent that export of item that contains Human biological materials/samples/products under chapter 30 is free subject to the NOC from Central Drugs Standard Control Organization (CDSCO) or Indian Council of Medical Research (ICMR). Department of Health Research (DHR). 

Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Vanijya Bhawan, New Delhi

Notification No. 72/2023-DGFT | Dated : 11thMarch, 2024

Subject: Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy.

S.O. 1249(E).—In exercise of powers conferred by Section 3 read with section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2023, the Central Government hereby amends Export Policy under chapter 30 related to Human Biological Samples, as under:

HS Code

Item Description Revised Export Policy Revised Policy Condition
30021020 Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes Free subject to NOC 1. Any human biological materials/samples/products which are related to activities  covered under the provision of Drugs & Cosmetics Act 1940   &    Rules thereunder are free for   export subject to No objection   from CDSCO.

2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DIIR.

30021091 Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
30021210 For diphtheria
30021220 For tetanus
30021230 For rabies
30021240 For snake venom
30021290 Other
30029010 Human Blood

2. Effect of the Notification:

Export Policy of Human Biological Samples under Chapter 30 of [ITC HS schedule-2 of export policy is amended to the extent that export of item that contains Human biological materials/samples/products under chapter 30 is free subject to the NOC from Central Drugs Standard Control Organization (CDSCO) or Indian Council of Medical Research (ICMR). Department of Health Research (DHR).

(Santosh Kumar Sarangi)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: dgft@nic.in

(Issued from F. No. 01/91/191/48/AM23/EC/e-35188)

Join Taxguru’s Network for Latest updates on Income Tax, GST, Company Law, Corporate Laws and other related subjects.

Leave a Comment

Your email address will not be published. Required fields are marked *

Search Post by Date
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930